Literature DB >> 19648586

Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy.

Jane C Caldwell1, Hussain Contractor, Sanjiv Petkar, Razwan Ali, Bernard Clarke, Clifford J Garratt, Ludwig Neyses, Mamas A Mamas.   

Abstract

AIMS: Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with chronic heart failure (CHF). Under-detection of asymptomatic paroxysmal AF (PAF) underestimates the true burden of AF in patients with CHF. We retrospectively studied the prevalence of asymptomatic PAF in 162 CHF patients through analysis of cardiac resynchronization therapy (CRT) device downloads to determine whether these episodes are associated with adverse outcomes. METHODS AND
RESULTS: An episode of AF was defined by mode switching on CRT devices with an atrial rate >200 for at least 30 s. Of the 101 patients thought to be persistently in sinus rhythm (SR), 27% were found to have significant paroxysms of AF, with the cumulative percentage of time in the 'mode-switch mode' (i.e. the AF burden) of 1.6 +/- 0.9%. Mortality was 19.2% in patients with newly identified PAF with hospitalization and thrombo-embolism rates of 42.3 and 2.1%, respectively, compared with mortality of 10.4% with hospitalization and thrombo-embolism rates of 41.8 and 1.9%, respectively, in patients persistently in SR (P= NS).
CONCLUSION: Analysis of data from CRT devices in a population of CHF patients with severe left ventricular dysfunction shows that a significant proportion of those perceived to be persistently in SR have undiagnosed paroxysms of AF but with relatively low burden. These episodes appear to be associated with a trend towards increased mortality but no effects on hospitalization or thrombo-embolism rates.

Entities:  

Mesh:

Year:  2009        PMID: 19648586     DOI: 10.1093/europace/eup201

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  19 in total

1.  Increasing knowledge and changing views in cardiac resynchronization therapy.

Authors:  Laszlo Buga; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

2.  Atrial fibrillation in obstructive sleep apnea.

Authors:  Sandeep K Goyal; Abhishek Sharma
Journal:  World J Cardiol       Date:  2013-06-26

3.  Left ventricular performance during triggered left ventricular pacing in patients with cardiac resynchronization therapy and left bundle branch block.

Authors:  Christoffer Tobias Witt; Mads Brix Kronborg; Ellen Aagaard Nohr; Jens Cosedis Nielsen
Journal:  J Interv Card Electrophysiol       Date:  2016-06-08       Impact factor: 1.900

Review 4.  How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

Authors:  Laszlo Buga
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

5.  Atrial fibrillation in heart failure: The sword of Damocles revisited.

Authors:  Muhammad A Khan; Fozia Ahmed; Ludwig Neyses; Mamas A Mamas
Journal:  World J Cardiol       Date:  2013-07-26

Review 6.  Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship.

Authors:  J C Caldwell; M A Mamas
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 7.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 8.  Home Screening for Detecting Subclinical Atrial Fibrillation.

Authors:  Renato Pietro Ricci; Taya V Glotzer
Journal:  J Atr Fibrillation       Date:  2015-12-31

9.  Genetic polymorphisms confer risk of atrial fibrillation in patients with heart failure: a population-based study.

Authors:  J Gustav Smith; Olle Melander; Marketa Sjögren; Bo Hedblad; Gunnar Engström; Christopher Newton-Cheh; Pyotr G Platonov
Journal:  Eur J Heart Fail       Date:  2012-11-06       Impact factor: 15.534

Review 10.  Anticoagulation in heart failure: current status and future direction.

Authors:  Mihai Gheorghiade; Muthiah Vaduganathan; Gregg C Fonarow; Stephen J Greene; Barry H Greenberg; Peter P Liu; Barry M Massie; Mandeep R Mehra; Marco Metra; Faiez Zannad; John G F Cleland; Dirk J van Veldhuisen; Ami N Shah; Javed Butler
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.